Alterations in regulatory T cells and immune checkpoint molecules in pancreatic cancer patients receiving FOLFIRINOX or gemcitabine plus nab-paclitaxel

被引：0
作者：
L. Sams
S. Kruger
V. Heinemann
D. Bararia
S. Haebe
S. Alig
M. Haas
D. Zhang
C. B. Westphalen
S. Ormanns
P. Metzger
J. Werner
O. Weigert
M. von Bergwelt-Baildon
F. Rataj
S. Kobold
S. Boeck
机构：
[1] Ludwig-Maximilians-University of Munich,Department of Internal Medicine III and Comprehensive Cancer Center, Grosshadern University Hospital
[2] German Cancer Consortium (DKTK),Laboratory for Experimental Leukemia and Lymphoma Research (ELLF), Department of Internal Medicine III, Grosshadern University Hospital
[3] Ludwig-Maximilians-University,Institute of Pathology, Faculty of Medicine
[4] Ludwig-Maximilians-University,Center of Integrated Protein Science Munich (CIPS
[5] University Hospital of the Ludwig-Maximilians-University,M) and Division of Clinical Pharmacology
[6] Ludwig-Maximilians-University,Department of General, Visceral and Transplantation Surgery
来源：
Clinical and Translational Oncology | 2021年 / 23卷
关键词：
FOLFIRINOX; Gemcitabine; Nab-paclitaxel; Pancreatic cancer; Immune checkpoints; Regulatory T cells;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2394 / 2401
页数：7
相关论文
共 29 条
[1]  
Quante AS(2016)Projections of cancer incidence and cancer-related deaths in Germany by 2020 and 2030 Cancer Med 5 2649-2656
[2]  
Von Hoff DD(2013)Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine N Engl J Med 369 1691-1703
[3]  
Conroy T(2011)FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer N Engl J Med 364 1817-1825
[4]  
Bear AS(2020)Challenges and opportunities for pancreatic cancer immunotherapy Cancer Cell 38 788-802
[5]  
Vonderheide RH(2019)Cytotoxic chemotherapy as an immune stimulus: a molecular perspective on turning up the immunological heat on cancer Front Immunol 10 1654-123
[6]  
O'Hara MH(2010)Pre-treatment with chemotherapy can enhance the antigenicity and immunogenicity of tumours by promoting adaptive immune responses Br J Cancer 102 115-2837
[7]  
Opzoomer JW(2014)Molecular pathways: the immunogenic effects of platinum-based chemotherapeutics Clin Cancer Res 20 2831-32
[8]  
Liu WM(2014)Immunological off-target effects of standard treatments in gastrointestinal cancers Ann Oncol 25 24-564
[9]  
Hato SV(2012)Regulatory T cells: mechanisms of differentiation and function Annu Rev Immunol 30 531-694
[10]  
Duffy AG(2017)Circulating regulatory T cell subsets predict overall survival of patients with unresectable pancreatic cancer Int J Oncol 51 686-1617
123